Flixotide Evohaler 250 micrograms per metered dose Pressurised Inhalation, Suspension

Licence status
Authorised: 19/08/2022
Active substances
Fluticasone propionate
Dosage Form
Pressurised inhalation, suspension
Licence number
PPA23176/019/002
Licence holder
Lexon Pharmaceuticals (Ireland) Limited

Product documents

Licence information

ATC code
R03BA Glucocorticoids, R03BA05 fluticasone
Legal supply status
Product subject to prescription which may be renewed (B)
Place of sale
Supply through pharmacies only
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
19/08/2022